Dr. Christopher John Taylor was born in December 1995 in Yorkshire, England. In June 2019, he completed his integrated MChem degree in Chemistry with Medicinal Chemistry at the University of Manchester. During his undergraduate studies, he undertook summer research placements within Prof. Nicholas Turner’s group at the University of Manchester and within Prof. Angela Russell’s group at the University of Oxford. His MChem research project was conducted under the supervision of Prof. Anthony Green, synthesising labelled tetrasaccharides for the study of LPMO mechanisms.

In September 2019, he commenced his PhD in Chemistry at the University of Manchester, working under the guidance of Prof. Anthony Green and Dr. Sarah Lovelock. He initially performed translation component engineering to enable the site-specific incorporation of non-canonical amino acids, including histidine analogues and dual hydrogen-bond donors, within proteins. He then generated a primitive photoenzyme functioning through a non-canonical dual hydrogen-bond donor, before subjecting the photoenzyme to iterative rounds of directed evolution towards the target transformation. His doctoral research was presented at the 2022 GRC Biocatalysis Conference (Boston, USA).

Upon completing his PhD in 2024, he worked as a Postdoctoral Researcher in Prof. Anthony Green’s group, with funding from the Gates Foundation. His postdoctoral work primarily focused on engineering transaminases, purine nucleoside phosphorylases and P450 monooxygenases to produce synthetic intermediates of anti-HIV and anti-TB pharmaceuticals.

He has recently moved to the IQCC to work as a Postdoctoral Researcher in Prof. Sílvia Osuna’sgroup. Now, he holds a postdoc position at TCBioSys. He will work on on designing novel enzymes as biocatalysts for the synthesis of industrially relevant products.

Welcome Christopher and good luck!

Girona, Sep 23rd, 2025
For more info: ges.iqcc@udg.edu